MA insider files Form 144 for $10.28M sale after option exercise

Rhea-AI Filing Summary

Mastercard (MA) Form 144 filing reports a proposed sale of 17,263 common shares to be executed through Morgan Stanley Smith Barney on the NYSE on 09/02/2025, with an aggregate market value of $10,276,491.27 and 897,274,172 shares outstanding. The filing states the shares were acquired and paid for on 09/02/2025 through exercise of stock options and paid in cash. The filer also disclosed two 10b5-1 sales by Sachin Mehra in the past three months: 17,816 shares sold on 08/19/2025 for $10,456,016.21 and 6,758 shares sold on 08/05/2025 for $3,828,164.39. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Positive

• Filing provides clear disclosure of the proposed sale, including broker, date, share count, and aggregate market value
• The shares being sold were acquired by exercise of stock options and paid in cash on the same date, indicating a routine liquidity event
• Previous 10b5-1 sales by the same person are disclosed, demonstrating use of pre-established trading plans and transparency

Negative

• Insider selling of 17,263 shares valued at $10,276,491.27 could be perceived negatively by some investors despite being small relative to outstanding shares
• Multiple recent insider sales totaling 24,574 shares in the past three months may prompt questions about ongoing insider disposition

Insights

Securities Analyst

TL;DR: Insider plans to sell 17,263 shares (≈$10.28M) after exercising options; recent 10b5-1 sales by the same person total 24,574 shares.

The Form 144 documents a proposed block sale following an option exercise and cash payment on the same date, indicating a liquidity event rather than a transfer from third-party acquisition. The disclosed aggregate market value of $10,276,491.27 for 17,263 shares implies a per-share price consistent with recent insider 10b5-1 sales. Materiality is modest relative to 897 million shares outstanding; this sale represents roughly 0.0019% of outstanding common stock, so it is unlikely to affect market supply or valuation. However, repeated 10b5-1 sales by the same individual in recent months (totaling 24,574 shares) should be noted for trend monitoring.

Corporate Governance Expert

TL;DR: Filing is a routine disclosure of an insider liquidity event with 10b5-1 plans previously used; controls and disclosure appear intact.

The filing includes the standard attestation regarding absence of undisclosed material information and references prior 10b5-1 transactions, which signals reliance on pre-established trading plans for some sales. The transaction arises from option exercise and immediate sale, a common executive compensation monetization. From a governance perspective, documentation of broker, dates, and past sales supports transparency. No indications of policy breaches or unusual transfer mechanisms are present in the filing text provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	17263	10276491.27	897274172	09/02/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/02/2025	Exercise of Stock Options	Issuer			17263	09/02/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SACHIN MEHRA 2000 Purchase Street Purchase NY 10577	Common	08/19/2025	17816	10456016.21
10b5-1 Sales for SACHIN MEHRA 2000 Purchase Street Purchase NY 10577	Common	08/05/2025	6758	3828164.39

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Mastercard's (MA) Form 144 disclose about the proposed sale?

The Form 144 reports a proposed sale of 17,263 common shares on 09/02/2025 via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $10,276,491.27.

How were the shares being sold by the filer acquired?

The filing states the shares were acquired on 09/02/2025 by exercise of stock options from the issuer and paid for in cash on that date.

Has the seller conducted other sales recently?

Yes. The filing discloses two 10b5-1 sales by Sachin Mehra: 17,816 shares sold on 08/19/2025 for $10,456,016.21 and 6,758 shares sold on 08/05/2025 for $3,828,164.39.

How material is this sale relative to Mastercard's outstanding shares?

The proposed 17,263-share sale represents approximately 0.0019% of the reported 897,274,172 shares outstanding, so it is not material to total share count.

Does the Form 144 assert any undisclosed material information?

By signing the notice the person represents they do not know of any material adverse information about the issuer that has not been publicly disclosed.